The chemical structure, pharmacological activity, and clinical progress of Gentianae Radix et Rhizoma

TL;DR

This review summarizes the chemical composition and health benefits of Gentianae Radix et Rhizoma, highlighting its potential for drug development.

Contribution

The paper provides the first comprehensive integration of chemical, pharmacological, and clinical data on Gentianae Radix et Rhizoma.

Findings

Gentianae Radix et Rhizoma contains 172 constituents, including key bioactive iridoids and triterpenoids.

Extracts from Gentiana species show anti-inflammatory, anti-cancer, and liver-protective effects through multiple pathways.

Gentiopicroside has demonstrated hepatoprotective and antiviral effects in clinical applications.

Abstract

As pivotal medicinal resources in the Gentiana genus (Gentianaceae), Gentianae Radix et Rhizoma exhibit remarkable chemical diversity and multi-target pharmacological activities. This review highlights G. scabra Bunge., Gentiana rhodantha Franch., Gentiana manshurica Kitag., Gentiana veitchiorum Hemsl., and other species, compiling 172 constituents from literature (2004–2024) and traditional sources: terpenoids (66 iridoids, 47 triterpenoids, and others), flavonoids, lignans, and alkaloids. Iridoids (e.g., gentiopicroside, swertiamarin) and triterpenoids are key bioactive agents. Pharmaco-logically, Gentiana extracts target NF-κB and MAPK pathways to suppress in-flammation and oxidative liver injury via Nrf2 activation, while inducing tumor cell apoptosis (Bax/Bcl-2) and S/G2-M phase arrest to inhibit lung/liver cancer proliferation. They enhance gastrointestinal repair, regulate motility, and mitigate chronic pain through central-peripheral analgesic synergy. Clinically, gentiopicroside demonstrates hepatoprotective, antiviral, and neuroprotective effects, with applications in herpes zoster, non-alcoholic fatty liver disease, and metabolic disorders. This review represents the first comprehensive integration of multidimensional chemi-cal-pharmacological-clinical data on Gentianae Radix et Rhizoma constituents, aiming to promote the expanded application of Gentianae Radix et Rhizoma in the pharma-ceutical field, provide a scientific basis for further development and utilization, and lay a foundation for subsequent research and industrial development.

Figures

Chemical structures of Monoterpenoids in Gentiana rhodantha Franch.

Chemical structures of iridoids in Gentianae Radix et Rhizoma.

Chemical structures of sesterpenoids in Gentiana scabra Bunge.

Chemical structures of triterpenoids in Gentianae Radix et Rhizoma.

Chemical structures of flavonoids in Gentianae Radix et Rhizoma.

Chemical structures of Lignans in Gentianae Radix et Rhizoma.

Chemical structures of Alkaloids in Gentianae Radix et Rhizoma.

Chemical structures of other constituents in Gentianae Radix et Rhizoma.

Clinical applications and Mechanisms of Gentianae Radix et Rhizoma and Its compound formulations.

Tables

TABLE 1. Monoterpenoids in Gentiana rhodantha Franch.

No.	Compound	Source	Ref.
1	(2E,6Z)-2,6-dimethyl-2,6-octadiene-1,8-dioic acid	Gentiana rhodantha Franch.	Zhou et al. (2023)
2	(2E,6E)-2,6-dimethyl-2,6-octa-diene-1,8-dioic acid	Gentiana rhodantha Franch.	Zhou et al. (2023)
3	(3S,6R)-dimethyloct-7-ene-2,3,6-triol	Gentiana rhodantha Franch.	Zhou et al. (2023)

TABLE 2. Iridoids in Gentianae Radix et Rhizoma.

No.	Compounds	Sources	Ref.
4	Loganic acid	Gentiana pedicellata	Liu (2004)
5	6'-O-β-D-glucopyranosyl loganic acid	Gentiana rhodantha Franch.	Xu et al., 2007
6	Gentiopicroside C	Gentiana manshurica Kitag.	Zhou et al. (2017)
7	Loganin	Gentiana scabra Bunge.	Xu et al. (2007)
8	Loganic acid 11-O-β-D-glucopyranosyl ester	Gentiana scabra Bunge.	Xu et al. (2007)
9	Caryoptoside	Gentiana scabra Bunge.	Xu et al. (2007)
10	4''-O-β-D-glucopyranosyllinearoside	Gentiana scabra Bunge.	Wang et al. (2017)
11	Gentianaside	Gentiana scabra Bunge.	Xu et al. (2007)
12	4''-O-β-D-glucosyl-6'-O-(4-O-β-D-glucosyl- caffeoyl)linearoside	Gentiana manshurica Kitag.	Yu (2006)
13	Tianmu Dihuang glycoside A	Gentiana manshurica Kitag.	Zhou et al. (2017)
14	Tianmu Dihuang glycoside E	Gentiana manshurica Kitag.	Zhou et al. (2017)
15	Globuloside A	Gentiana triflora Pall.	Olennikov et al. (2015)
16	Cornusoside A	Gentiana triflora Pall.	Olennikov et al. (2015)
17	Cornolactone A	Gentiana triflora Pall.	Olennikov et al. (2015)
18	6,9-epi-8-O-acetylshanziside methyl ester	Gentiana triflora Pall.	Olennikov et al. (2015)
19	5,9-epi-Penstemoside	Gentiana triflora Pall.	Olennikov et al. (2015)
20	6-keto-8-acetylhookgrass glycoside	Gentiana scabra Bunge.	Olennikov et al. (2015)
21	6,7-dehydro-8-acetylhookgrass glycoside	Gentiana scabra Bunge.	Olennikov et al. (2015)
22	Scrophulariadioside A	Gentiana manshurica Kitag.	Zhou et al. (2017)
23	Rehmannioside B	Gentiana manshurica Kitag.	Zhou et al. (2017)
24	Rehmannioside C	Gentiana manshurica Kitag.	Zhou et al. (2017)
25	Gentiopicroside	Gentiana scabra Bunge.	Zhang et al. (2019)
26	2H-gentiopicroside	Gentiana rigescens Franch.	Ye et al. (2018)
27	6'-O-β-D-glucopyranosylgentiopicroside	Gentiana scabra Bunge.	Zhang et al. (2019)
28	4'-O-β-D-glucopyranosylgentiopicroside	Gentiana scabra Bunge.	Zhang et al. (2019)
29	Olivieroside C	Gentiana crassicaulis	Sun and Xia (1984)
30	(−)-Swertiamarigenin a	Gentiana scabra Bunge.	Wang (2014)
31	Scabrans G3	Gentiana scabra Bunge.	Zhang et al. (2019)
32	Scabrans G4	Gentiana scabra Bunge.	Zhang et al. (2019)
33	Scabrans G5	Gentiana scabra Bunge.	Zhang et al. (2019)
34	Gentiotrifloroside	Gentiana scabra Bunge.	Jiang et al. (2008)
35	2'-(2,3-dihydroxybenzoyl) Gentiopicroside	Gentiana rigescens Franch.	Zhao et al. (2009)
36	Gentiotrifloroside	Gentiana scabra Bunge.	Guo and Piao (2011)
37	2'-(o,m-dihydroxybenzyl)sweroside	Gentiana scabra Bunge.	Guo and Piao (2011)
38	4'''-O-β-D-glucosyltrifloroside	Gentiana scabra Bunge.	Wang (2015)
39	Trifloroside	Gentiana scabra Bunge.	Hu and Li (2002)
40	Rindoside	Gentiana scabra Bunge.	Li et al., 2011
41	4'''-O-β-D-glucosylscabraside	Gentiana scabra Bunge.	Wan (2022)
42	6'-O-acetylsweroside	Gentiana straminea	Zhu et al. (2021)
43	6'-O-acetyl-3'-O-[3-(β-D-glucopyranosyloxy)-2-hydroxybenzoyl]sweroside	Gentiana manshurica Kitag.	Yu (2006)
44	(1S,5R,9R)-deglucosyltrifloroside	Gentiana triflora Pall.	Li and Wang (2023)
45	(1S,5R,9R)-scabraside	Gentiana triflora Pall.	Li and Wang (2023)
46	Deglucoscabraside	Gentiana triflora Pall.	Li and Wang (2023)
47	3'-O-β-D-glucopyranosyl sweroside	Gentiana scabra Bunge.	Zhang (2015)
48	6'-O-β-D-glucopyranosyl loganic acid	Gentiana rigescens Franch.	Liu et al. (2024)
49	Scabraside	Gentiana rigescens Franch.	Liu et al. (2024)
50	3'-(2,3-dihydroxybenzoyl) gentian glycoside	Gentiana rigescens Franch.	Zhao et al. (2009)
51	Swertiamarin	Gentiana scabra Bunge.	Hu and Li (2002)
52	Amaroswerin	Gentiana scabra Bunge.	Zhang, 2015
53	Deglucogelidoside	Gentiana scabra Bunge.	Li and Wang (2023)
54	Swertiamarin tetraacetate	Gentiana scabra var. Buergeri	Li et al. (2024)
55	Gentiascabraside A	Gentiana scabra Bunge.	Guo and Piao (2011)
56	6β-hydroxyswertiajaposide A	Gentiana scabra Bunge.	Zhang et al. (2019)
57	2'-(2,3-dihydroxybenzoyl) Gentiopicroside	Gentiana scabra Bunge.	Zhang et al. (2019)
58	Swertiajaposide A	Gentiana scabra Bunge.	Zhang et al. (2019)
59	Honeysuckle glycoside	Gentiana scabra Bunge.	Xu et al. (2007)
60	8-epi-kingiside	Gentiana scabra Bunge.	Xu et al. (2007)
61	1-O-β-D-glucosyl-4-epiamplexine	Gentiana scabra Bunge.	Zhang et al. (2019)
62	1-O-β-D-glucopyranosylamplexine	Gentiana scabra Bunge.	Zhang et al. (2019)
63	Gentiorigenoside A	Gentiana scabra Bunge.	Liu et al. (2024)
64	Secologanoside	Gentiana rhodantha Franch.	Xu et al. (2007)
65	Gentiolactone	Gentiana scabra Bunge.	Li and Wang (2023)
66	Rigenolide A	Gentiana rigescens Franch.	Zhao et al. (2009)
67	(+)-Gentiovarisin a	Gentiana scabra Bunge.	Zhang et al. (2023)
68	(-)-Gentiovarisin a	Gentiana scabra Bunge.	Zhang et al. (2023)
69	Gentiovarisin B	Gentiana scabra Bunge.	Zhang et al. (2023)
70	Villoside	Gentiana scabra Bunge.	Wang (2014)
71	Villosolside B	Gentiana scabra Bunge.	Wang (2014)

TABLE 3. Sesterterpenoid in Gentiana scabra Bunge.

No.	Compounds	Sources	Ref.
72	(+)-Syringaresinol	Gentiana scabra Bunge.	Ye et al. (2023)
73	Pranferin	Gentiana scabra Bunge.	Li (2023)

TABLE 4. Triterpenoids in Gentianae Radix et Rhizoma.

No.	Compounds	Sources	Ref.
74	3β,11α-dihydroxyurs-12-ene	Gentiana scabra Bunge.	Wang et al. (2023)
75	3β-hydroxy-11-oxours-12-ene	Gentiana scabra Bunge.	Wang et al. (2023)
76	Gentirigenic acid	Gentiana rigescens Franch.	Yang and Wang (2005)
77	Gentirigeoside A	Gentiana rigescens Franch.	Yang and Wang (2005)
78	Gentirigeoside B	Gentiana rigescens Franch.	Yang and Wang (2005)
79	Gentirigeoside C	Gentiana rigescens Franch.	Yang and Wang (2005)
80	Gentirigeoside D	Gentiana rigescens Franch.	Yang and Wang (2005)
81	Gentirigeoside E	Gentiana rigescens Franch.	Yang and Wang (2005)
82	(20S)-dammara-13(17),24-dien-3-one	Gentiana scabra Bunge.	Cao et al. (2012)
83	(20R)-dammara-13(17),24-dien-3-one	Gentiana scabra Bunge.	Cao et al. (2012)
84	Α-amyrin	Gentiana rhodantha Franch.	Xie et al. (2021)
85	Α-amyrin palmitate	Gentiana rhodantha Franch.	Xie et al. (2021)
86	Ursolic acid	Gentiana scabra Bunge.	Yu (2006)
87	Lupeolone	Gentiana manshurica Kitag.	Yu (2006)
88	Lupeol	Gentiana manshurica Kitag.	Yu (2006)
89	Lupeol palmitate	Gentiana scabra Bunge.	Cao et al. (2012)
90	17β,21β-epoxyhopan-3-one	Gentiana scabra Bunge.	Cao et al. (2012)
91	Hop-17(21)-en-3-one	Gentiana scabra Bunge.	Cao et al. (2012)
92	Hop-17(21)-en-3β-ol	Gentiana scabra Bunge.	Cao et al. (2012)
93	Β-amyrin acetate	Gentiana scabra Bunge.	Chen et al. (2008)
94	Uvaol 3-O-linoleate	Gentiana scabra Bunge.	Jia et al. (2012)
95	Erythrodiol 3-O-linoleate	Gentiana scabra Bunge.	Jia et al. (2012)
96	Uvaol 3-O-stearate	Gentiana scabra Bunge.	Jia et al. (2012)
97	Erythrodiol 3-O-stearate	Gentiana scabra Bunge.	Jia et al. (2012)
98	Chirat-16-en-3-one	Gentiana scabra Bunge.	Cao et al. (2012)
99	Chiratenol	Gentiana manshurica Kitag.	Yu (2006)
100	Chirat-17(22)-en-3-one	Gentiana scabra Bunge.	Cao et al. (2012)
101	Oleanolic acid	Gentiana scabra Bunge.	Li (2023)
102	3β-O-benzoyl-2α-hydroxyolean-12-en-28-oic acid	Gentiana scabra Bunge.	Kikuchi et al. (2005)
103	3β-O-(4′-hydroxybenzoyl)-2α-hydroxyolean-12-en-28-oic acid	Gentiana scabra Bunge.	Kikuchi et al. (2005)
104	3β-O-benzoyl-2α-hydroxyurs-12-en-28-oic acid	Gentiana scabra Bunge.	Kikuchi et al. (2005)
105	3,4-seco-ursan-28-hydroxy-12-en-3-oic acid	Gentiana scabra Bunge.	Kikuchi et al. (2005)
106	11β-hydroxy-chairat-16-16-en-3-one	Gentiana scabra Bunge.	Kikuchi et al. (2005)
107	19-hydroxy-2,3-seco-urs-12-ene-2,3,28-trioic acid 3-methyl ester	Gentiana rhodantha Franch.	Zhou et al. (2023)
108	Pomolic acid	Gentiana rhodantha Franch.	Zhou et al. (2023)
109	2α,19α-dihydroxy-3-oxo-urs-12-ene-28-oic acid	Gentiana rhodantha Franch.	Zhou et al. (2023)
110	Ursolic acid lactone	Gentiana rhodantha Franch.	Zhou et al. (2023)
111	Uvaol	Gentiana rhodantha Franch.	Zhou et al. (2023)
112	Ilelatifol D	Gentiana rhodantha Franch.	Zhou et al. (2023)
113	Hederagenin	Gentiana rhodantha Franch.	Zhou et al. (2023)
114	2α,3β,23-trihydroxy-12-ene-28-oleanolic acid	Gentiana rhodantha Franch.	Zhou et al. (2023)
115	2α,3β,23-trihydroxyoleana-11,13(18)-dien-28-oic acid	Gentiana rhodantha Franch.	Zhou et al. (2023)
116	Oleanolic acid	Gentiana rhodantha Franch.	Zhou et al. (2023)
117	Ursolic aldehyde	Gentiana rhodantha Franch.	Zhou et al. (2023)
118	2α,3β,24-trihydroxy-12-ene-28-oleanolic acid	Gentiana rhodantha Franch.	Zhou et al. (2023)
119	Erythrodiol	Gentiana scabra Bunge.	Wang et al. (2023)
120	Roburie acid	Gentiana scabra Bunge.	Wang et al. (2023)

TABLE 5. Flavonoid in Gentianae Radix et Rhizoma.

No.	Compounds	Sources	Ref.
121	Oliganthaxthanone A	Gentiana manshurica Kitag.	Wu et al. (2017)
122	Oliganthaxthanone B	Gentiana manshurica Kitag.	Wu et al. (2017)
123	1,5-dihydroxy-2,3,4-trimethoxyxanthone	Gentiana manshurica Kitag.	Wu et al. (2017)
124	Bannaxanthone I	Gentiana manshurica Kitag.	Wu et al. (2017)
125	Artomandin	Gentiana manshurica Kitag.	Wu et al. (2017)
126	Polyhongkongenosides A	Gentiana manshurica Kitag.	Wu et al. (2017)
127	Acremoxanthone D	Gentiana manshurica Kitag.	Wu et al. (2017)
128	Sporormielloside	Gentiana manshurica Kitag.	Wu et al. (2017)
129	Pinetoxanthone	Gentiana manshurica Kitag.	Wu et al. (2017)
130	Mangiferin	Gentiana manshurica Kitag.	Li X. et al. (2018)
131	Arnicaefolin	Gentiana straminea	Li X. et al. (2018)
132	Gentiakochianin	Gentiana straminea	Li X. et al. (2018)
133	Gentian xanthone phenol	Gentiana straminea	Li X. et al. (2018)
134	Kaempferol	Gentiana crassicaulis	Li (2023)
135	Saponarin	Gentiana scabra Bunge.	Lian et al. (2018)
136	6-Demethoxy-7-methylcapillarisin	Gentiana scabra Bunge.	Lian et al. (2018)
137	Rutin	Gentiana scabra Bunge.	Zhang et al. (2014)
138	Luteolin	Gentiana olivieri	Zhang et al. (2014)
139	Isorhamnetin	Gentiana olivieri	Zhang et al. (2022)
140	Quercetin	Gentiana scabra Bunge.	Li et al. (2015)
141	Trifolirhizin	Gentiana scabra Bunge.	Isakovic et al. (2008)
142	Isovitexin	Gentiana scabra Bunge.	Li X. et al. (2018)
143	Isoorientin	Gentiana scabra Bunge.	Li X. et al. (2018)
144	Isovitexin-7-O-glucoside	Gentiana scabra Bunge.	Li X. et al. (2018)
145	Isosakuranetin	Gentiana scabra Bunge.	Ruan et al. (2015)
146	Hyperin	Gentiana scabra Bunge.	Yang et al. (2018)
147	Lonicerin	Gentiana scabra Bunge.	Li et al. (2016)
148	Chrysoeriol	Gentiana scabra Bunge.	Li et al. (2016)
149	Isoorientin-7-O-glucoside	Gentiana scabra Bunge.	Deng (2015)
150	Luteolin-7-O-glucoside	Gentiana scabra Bunge.	Deng (2015)

TABLE 6. Lignans in Gentianae Radix et Rhizoma.

No.	Compounds	Sources	Ref.
151	L-sesamin	Gentiana scabra Bunge.	Li (2023)
152	Liriodendrin	Gentiana scabra Bunge.	Li (2023)
153	Tortoside B	Gentiana scabra Bunge.	Li X. et al. (2018)
154	(-)-Syringaresinol-O-β-D-glucoside	Gentiana yunnanensis	Yang (2014)
155	(-)-Pinoresinol-O-β-D-glucoside	Gentiana yunnanensis	Yang (2014)
156	4,4′-Dimethoxy-3′-hydroxy-7,9′:7′,9-diepoxylignan-3-O-β-D-glucopyranoside	Gentiana yunnanensis	Yang (2014)
157	Syringaresinol-4′-O-β-D-glucopyranoside	Gentiana yunnanensis	Yang (2014)
158	Dehydrodiconiferyl alcohol-4-O-β-D-glucopyranoside	Gentiana yunnanensis	Yang (2014)
159	(7S,8R)-Balanophonin-4-O-β-D-glucopyranoside	Gentiana yunnanensis	Yang (2014)
160	(7S,8R)-Dehydrodiconiferyl alcohol-9′-O-β-D-glucopyranoside	Gentiana yunnanensis	Yang (2014)
161	Lariciresinol-4-O-β-D-glucopyranoside	Gentiana yunnanensis	Yang (2014)

TABLE 7. Alkaloids in Gentiana scabra Bunge.

No.	Compounds	Sources	Ref.
162	Gentianine	Gentiana scabra Bunge.	Ning et al. (2017)
163	Gentialutine	Gentiana scabra Bunge.	Ning et al. (2017)
164	Gentiamine	Gentiana scabra Bunge.	Ning et al. (2017)
165	Gentioflavine	Gentiana scabra Bunge.	Ning et al. (2017)

TABLE 8. Other constituents in Gentianae Radix et Rhizoma.

No.	Compounds	Sources	Ref.
166	Gentiobiose	Gentiana scabra Bunge.	Ye et al. (2023)
167	Gentianose	Gentiana scabra Bunge.	Ye et al. (2023)
168	Salicylic acid	Gentiana scabra Bunge.	Ye et al. (2023)
169	Ferulic acid	Gentiana scabra Bunge.	Ye et al. (2023)
170	Β-Sitosterol	Gentiana scabra Bunge.	Ye et al. (2023)
171	Inokosterone	Gentiana scabra Bunge.	Ye et al. (2023)
172	Cholesterol	Gentiana scabra Bunge.	Ye et al. (2023)

TABLE 9. Anti-inflammatory and analgesic compounds in Gentianae Radix et Rhizoma: Bioactive components and mechanisms of action.

No.	Active component	Chemical class	Mechanisms of action
6	Gentiopicroside	Iridoid	Inhibits IKKβ phosphorylation
			Blocks NF-κB nuclear translocation
			Downregulates COX-2, TNF-α
			Central: downregulates NMDAR-NR2B expression
			Peripheral: inhibits substance P release
			Peripheral: activates μ-opioid receptors
7	Loganin	Iridoid	Modulates inflammatory microenvironment
51	Swertiamarin	Iridoid	Suppresses JNK/p38-MAPK pathway, reduces IL-6 and IL-1β secretion
- 1	Gentianae Radix et Rhizoma	-	Inhibiting PGE2 synthesis and TRPV1 channel activation

TABLE 10. Hepatoprotective and Choleretic compounds in Gentianae Radix et Rhizoma: Bioactive components and mechanisms of action.

No.	Active component	Chemical class	Mechanisms of action
6	Gentiopicroside	Iridoid	Inhibits P2X7/NLRP3 inflammasome axis
			Modulates FASN/CPT1 lipid metabolism
51	Swertiamarin	Iridoid	Upregulates BSEP/MRP for bile acid efflux
			Activates CYP3A4/2E1 for detoxification
- 1	Gentianae Radix et Rhizoma	-	Increase hepatocyte membrane fluidity
			Enhance hepatic microcirculation
			Alleviate biliary dysfunction in thioacetamide-induced models

TABLE 11. Antitumor component in Gentianae Radix et Rhizoma: Bioactive components and mechanisms of action.

No.	Active component	Chemical class	Mechanisms of action
25	Gentiopicroside	Iridoid	Activates p38/MAPK pathway
			Upregulates bax
			Downregulates bcl-2
			Induces cell cycle arrest (S-phase, G2/M-phase, G0/G1-phase)
- 1	Gentianae Radix et Rhizoma polysaccharides	Polysaccharides	Enhances thymic and splenic indices
			Boosts immune responses in tumor-bearing mice
132	Gentiakochianin	Flavonoid	Induces apoptosis in glioma U251 cells by reducing mitochondrial membrane potential and promoting ROS generation
138	Luteolin	Flavonoid	Inhibits NSCLC proliferation
			Induces autophagy via suppression of PI3K/Akt/mtor/p70s6k signaling axis
- 1	Crude Gentianae Radix et Rhizoma extracts	Extract mixture	Inhibits proliferation in various cancer cell lines (A549, HCT-116, PC-3, MCF-7)
			Suppresses tumor growth in mouse sarcoma S180
98	Chirat-16-en-3-one	Triterpenoids	Antiproliferative effects against cervical cancer hela cells
99	Chiratenol	Triterpenoids	Antiproliferative effects against cervical cancer hela cells
15	Globuloside A	Iridoid glycoside	Inhibits hepg2 cell viability
16	Cornusoside A	Iridoid glycoside	Inhibits hepg2 cell viability
17	Cornolactone A	Iridoid	Inhibits hepg2 cell viability
18	6,9-epi-8-O-acetylshanziside methyl ester	Iridoid glycoside	Inhibits hepg2 cell viability

TABLE 12. Gastrointestinal-Regulating Bioactive compounds in Gentianae Radix et Rhizoma: mechanisms of action

No.	Active component	Chemical class	Mechanisms of action
25	Gentiopicroside	Iridoid glycoside	Promotion of Gastric Motility: Upregulates motilin receptor expression, downregulates VIPR2 levels, enhances gastric emptying and intestinal peristalsis.
			Gastric Mucosal Protection: Upregulates HSP70, restores EGF and VEGF levels, and promotes mucosal repair in ethanol-induced injury models.

TABLE 13. Nervous system-Regulating Bioactive compounds in Gentianae Radix et Rhizoma: mechanisms of action.

No.	Active component	Chemical class	Mechanisms of action
25	Gentiopicroside	Iridoid	Antioxidant (activates PI3K/Akt pathway)
			Anti-Parkinsonian (inhibits α-synuclein aggregation)
			Antidepressant (modulates monoamine neurotransmitters)
			Alleviates pain-depression comorbidity (downregulates glun2b)
			Reduces morphine-induced addictive behaviors (modulates opioid receptor signaling and dopamine reward pathways)
- 1	Bellidifolin	Xanthone	Enhances neuronal survival via insulin receptor pathways (PI3K/Akt, Ras/Raf/ERK)
			Elevates SOD activity
			Reduces ROS and MDA levels
171	Inokosterone	Phytoecdysteroid	Attenuates mitochondrial dysfunction-mediated apoptosis in oxidative stress models
- 1	Gentisides A/B	Iridoid glycosides	Enhance neuronal survival under oxidative stress (activates insulin receptor pathways)
			Elevates SOD activity
			Reduces ROS and MDA levels
- 1	Amarogentin	Iridoid	Enhances neuronal survival under oxidative stress (activates insulin receptor pathways)
			Elevates SOD activity
			Reduces ROS and MDA levels
162	Gentianine	Alkaloid	Enhances central nervous system excitability
			Potentially through GABA ergic system modulation

TABLE 14. Antioxidant component in Gentianae Radix et Rhizoma: Bioactive components and mechanisms of action.

No.	Active component	Chemical class	Mechanisms of action
78	Gentirigeoside B	Iridoids	Inhibit mtor/Sch9/Rim15/Msn signaling pathway,
			Enhance autophagy
- 1	Flavonoid extracts	Flavonoids	Scavenge DPPH radicals, antioxidant activity is directly proportional to total flavonoid content
- 1	GSP-IIa	Proteoglycans	Scavenge DPPH radicals, exhibit stable antioxidant activity
- 1	GSP-IIb	Proteoglycans	Scavenge DPPH radicals, exhibit stable antioxidant activity

TABLE 15. Other activities of Gentianae Radix et Rhizoma.

Activity type	Active component	Mechanisms of action
Antiviral	Crude extracts	Inhibits adenovirus, rhinovirus, respiratory syncytial virus
Diuretic	Underground extracts	Promotes water-salt metabolism
Skin barrier repair	Gentiopicroside	Improves epidermal barrier function
Anti-diabetic nephropathy	Crude extracts	Modulates TGR5/β-arrestin2/NF-κB pathway

Full text

1 Introduction

There are approximately 400 species of Gentiana, widely distributed in the temperate regions of the Northern Hemisphere and the alpine regions of the tropics, including Europe, Asia, the northern part of Australia and New Zealand, North America and along the Andes to Cape Horn, and the northern part of Africa. In China, there are about 247 species, found throughout the country, with most species concentrated in the mountainous areas of the southwest, primarily growing in alpine talus slopes, alpine meadows, and shrublands (Editorial Committee of Flora of China and Chinese Academy of Sciences, 1988; Wang et al., 2009; Che and Liang, 2008).

The Gentiana genus is composed of a diverse array of plants. Adhering to the principle of combining characteristics of vegetative and reproductive organs, the Gentiana genus is divided into 15 sections (Dong et al., 2017). The section Gentiana, represented by the traditional Chinese medicinal herb Gentianae Radix et Rhizoma, is known for its bitter taste and cold nature, which possess the effects of purging excess fire in the liver and gallbladder, as well as clearing damp-heat in the lower jiao. It is used in the treatment of diseases such as excessive heat in the liver meridian, convulsions, mania, jaundice, dysentery, Japanese encephalitis, sore throat, red eyes, scrotal swelling and pain, and damp itchiness in the genital area (Che and Liang, 2008; Jiao et al., 2024). Gentianae Radix et Rhizoma, derived from perennial herbs of the Gentianaceae family, was first recorded in the “Shen nong Bencaojing” during the Han Dynasty (202 B.C. – 220 C.D.) and is categorized as a moderate herb. It is known for its efficacy in treating cold and heat within the bones, convulsions, expelling noxious qi, healing severe injuries, stabilizing the functions of the five viscera, and detoxifying. Prolonged use is believed to enhance memory, invigorate the body, and delay aging (Liu, 2022). The 2020 edition of the “Chinese Pharmacopoeia” stipulates that Gentiana is the dried root and rhizome of Gentiana manshurica Kitag., G. scabra Bge., Gentiana triflora Pall., or G. rigescens Franch., which belong to the Gentianaceae family. These plants are perennial herbs, and their roots and rhizomes are used medicinally (Chinese Pharmacopoeia Commission, 2020).

As a traditional remedy for clearing heat and drying dampness, Gentianae Radix et Rhizoma demonstrates a variety of pharmacological actions in clinical settings. Modern pharmacological research indicates that Gentianae Radix et Rhizoma possesses hepatoprotective, choleretic, anti-inflammatory, analgesic, antimicrobial, antiviral, antiallergic, antitumor, neuroprotective, and stomachic activities. These diverse pharmacological effects are associated with its complex chemical structure, particularly with compounds such as gentiopicroside, swertiamarin, amarogentin, linarin, oleanolic acid, gentianine, and polysaccharides, highlighting the significant value of Gentianae Radix et Rhizoma (Jiao et al., 2024; Ning et al., 2017; Jiang et al., 2019; Xiao et al., 2019).

2 Chemical composition

For Gentianae Radix et Rhizoma are rich in diverse chemical constituents, primarily including terpenoids (iridoids and triterpenoids), flavonoids, lignans, and alkaloids. Among these, iridoids such as gentiopicroside, swertiamarin, and sweroside are not only the most abundant phytochemicals in Gentianae Radix et Rhizoma but also serve as key bioactive components responsible for their pharmacological activities (Song, 1986; Ye et al., 2023). Unless otherwise specified, all chemical constituents discussed in this section were isolated from roots/rhizomes, as defined in the Chinese Pharmacopoeia (2020). Compounds one to three were isolated from flowers of Gentiana rhodantha Franch. (non-pharmacopeial species), included for comparative chemical profiling.

2.1 Terpenoids

This article primarily describes 120 terpenoid compounds identified in G. rigescens, including 3 monoterpenes (1–3), 68 iridoids (4–71), 2 sesterterpenes (72–73), and 47 triterpenoids (74–120).

2.1.1 Monoterpenoid

Monoterpenoid compounds in Gentianae Radix et Rhizoma have been relatively less reported. Nevertheless, recent studies have gradually unveiled some monoterpenoid compounds within it. For instance, three monoterpenoid compounds were isolated from the flowers of Gentiana rhodantha, among which compound 1 is a novel compound, while compounds 2 and 3 are new natural products. These findings suggest that there may be more undiscovered monoterpenoid compounds in Gentianae Radix et Rhizoma, warranting further investigation. The ^1^H NMR and ^13^C NMR data for these compounds have been assigned (Zhou et al., 2023). Monoterpenoid compounds from Gentianae Radix et Rhizoma are presented in Table 1, and their chemical structures are illustrated in Figure 1.

Chemical structures of Monoterpenoids in Gentiana rhodantha Franch.

2.1.2 Iridoids

The majority of iridoid components in Gentianae Radix et Rhizoma are secoiridoids, which are commonly glycosylated at the C-1 position. The isolated iridoids are primarily classified into regular iridoids, 4-demethylated iridoids, and secoiridoids (Ye et al., 2023). The regular iridoids include loganic acid (4), 6′-O-β-D-glucopyranosyl loganic acid (5), and loganin (7); the 4-demethylated iridoids include Scrophulariadioside A (22), Rehmannioside B (23), Rehmannioside C (24); and the secoiridoids include gentiopicroside (25), Gentiotrifloroside (36), and Swertiamarin (51). For detailed information on the iridoid components in Gentianae Radix et Rhizoma, refer to Table 2 and Figure 2.

Chemical structures of iridoids in Gentianae Radix et Rhizoma.

2.1.3 Sesterterpenoids

Sesterterpenoid compounds found in gentians are similar in scarcity to monoterpenoids. Liu et al. identified the sesterterpenoid pranferin from a methanol extract of G. scabra Bunge. (Liu, 2004). Specific information on sesterterpenoid constituents from Gentiana can be found in Table 3 and Figure 3.

Chemical structures of sesterpenoids in Gentiana scabra Bunge.

2.1.4 Triterpenoids

Triterpenoids isolated from Gentiana plants mainly include dammarane-type compounds, characterized by a β-configured angular methyl group at the C-8 position, such as gentirigenic acid (76), gentirigeoside A (77), and gentirigeoside B (78); ursane-type compounds, with A/B, B/C, and C/D rings in a trans configuration and D/E rings mostly in a cis configuration, such as α-amyrin (84), α-amyrin palmitate (85), and ursolic acid (86); and lupane-type compounds, featuring a five-membered E ring with isopropyl substitution, such as 17β,21β-epoxyhopan-3-one (90), hop-17 (21)-en-3-one (91), and hop-17 (21)-en-3β-ol (92). Specific information on triterpenoid constituents from Gentianae Radix et Rhizoma can be found in Table 4 and Figure 4. Additionally, purified dammarane-type triterpenoids from Gentiana rigescens exhibited in vitro antifungal activity against Glomerella cingulata (inhibition zones: 0.8–2.0 cm) in a disk diffusion assay at 1 mg/mL, with Carbendazim as a positive control after 72 h of incubation (Xu et al., 2007).

Chemical structures of triterpenoids in Gentianae Radix et Rhizoma.

2.2 Flavonoid

The flavonoid constituents in G. rigescens are primarily composed of benzochromones and flavonoid glycosides. Representative compounds include oliganthaxthanone A (121), pinetoxanthone (122), mangiferin (130), luteolin (138), kaempferol (134), quercetin (140), isoorientin (142), isovitexin (143), and their derivatives (Liu, 2004; Zhou et al., 2017; Wang, 2015; Yu, 2006; Olennikov et al., 2015). as shown in Table 5 and Figure 5.

Chemical structures of flavonoids in Gentianae Radix et Rhizoma.

2.3 Lignans

Representative lignans isolated from G. rigescens include L-sesamin (151), liriodendrin (152), tortoside B (153), and lignan glycosides such as (−)-syringaresinol-O-β-D-glucoside (154), (−)-pinoresinol-O-β-D-glucoside (155), syringaresinol-4′-O-β-D-glucopyranoside (157), and lariciresinol-4-O-β-D-glucopyranoside (161) (Liu, 2004; Zhang et al., 2019; Ye et al., 2018). Specific information on lignans constituents from Gentianae Radix et Rhizoma can be found in Table 6 and Figure 6.

Chemical structures of Lignans in Gentianae Radix et Rhizoma.

2.4 Alkaloids

Since the 1950s, several alkaloids, including gentianine (162), gentialutine (163), gentiamine (164), and gentioflavine (165), have been isolated from G. rigescens (Sun and Xia, 1984). However, studies suggest that these alkaloids may not be naturally occurring in the plant but rather artifacts formed during extraction. For instance, gentianine and gentialutine are proposed to arise from the conversion of gentiopicroside in the presence of ammonia during processing. Such interconversions between constituents not only influence the diversity and abundance of alkaloids but also modulate their pharmacological profiles. For example, gentianine exhibits significant anti-inflammatory, sedative, and antibacterial activities, whereas its precursor gentiopicroside primarily demonstrates hepatoprotective, anti-inflammatory, and immunomodulatory effects (Ning et al., 2017). Specific information on alkaloids constituents from Gentianae Radix et Rhizoma can be found in Table 7 and Figure 7.

Chemical structures of Alkaloids in Gentianae Radix et Rhizoma.

2.5 Other constituents

Beyond terpenoids, flavonoids, lignans, and alkaloids, Gentianae Radix et Rhizoma contain diverse secondary metabolites. Polysaccharides such as gentiobiose (166) have been isolated (Wang, 2014; Jiang et al., 2008). Phenolic acids, including salicylic acid (168) and ferulic acid (169), are also documented (Liu, 2004). Additionally, Gentiana contains amino acids (e.g., threonine, valine, methionine) and essential minerals such as calcium (Ca), copper (Cu), iron (Fe), zinc (Zn), and manganese (Mn) (Ye et al., 2023). Steroidal compounds, including β-sitosterol (170) and inokosterone (171), have been identified (Zhao et al., 2009; Guo and Piao, 2011). The specific information is presented in Table 8 and Figure 8.

Chemical structures of other constituents in Gentianae Radix et Rhizoma.

The identified iridoids and flavonoids not only contribute to the pharmacological efficacy but also serve as pivotal quality markers (Q-markers) for the standardization of Gentianae Radix et Rhizoma. Extraction methodologies across cited studies predominantly utilized methanol or ethanol (60%–95%) via reflux/maceration. For instance: Iridoids (e.g., gentiopicroside): 70% ethanol reflux, 2 h; Triterpenoids: Methanol maceration (48 h) silica gel chromatography; Polysaccharides: Hot water extraction (90 °C, 3 h); Comparative data suggest methanol outperforms ethyl acetate for iridoid yield (Δ = 12–18%), while ultrasound-assisted extraction reduces processing time by 40%.

Key compounds such as gentiopicroside, swertiamarin, and luteolin are critical for species authentication and ensuring batch-to-batch consistency, with HPLC-UV analysis typically requiring a relative standard deviation (RSD) of less than 5% for these benchmarks (Hu and Li, 2002). The establishment of these Q-markers bridges the chemical profiles with the efficacy, laying a foundation for quality control in pharmaceutical applications.

3 Biological activities

Gentianae Radix et Rhizoma, a traditional Chinese medicinal herb commonly known as Longdan, has been utilized for millennia to clear heat, dry dampness, and purge liver-gallbladder fire. Its therapeutic applications were first documented in the Shennong Bencao Jing (ca. 200 CE), where it was classified as a middle-grade herb with bitter-cold properties, noted for treating bone-interstice disorders, convulsions, and parasitic toxins, while enhancing cognition and longevity with prolonged use (Liu, 2022). Subsequent dynastic texts expanded its pharmacological profile. The Mingyi Bielu (Liang Dynasty) highlighted its efficacy in resolving gastric heat, seasonal febrile diseases, and heat-type diarrhea (Li et al., 2011), establishing its foundational role in heat-clearing and damp-drying therapies.

During the Song-Yuan period, the Taiping Shenghui Fang introduced the prototype of Longdan Xiegan Tang (Gentian Liver-Draining Decoction), combining gentian with Bupleurum and Scutellaria to address liver-gallbladder fire excess syndromes (Wan, 2022). Kou Zongshi’s Bencao Yanyi emphasized its morphological distinction as a short-rooted herb with intense bitterness (Zhu et al., 2021). By the Ming-Qing era, Li Shizhen’s Bencao Gangmu systematized its uses, including throat pain, wind-heat night sweats, and ocular inflammation, while noting enhanced efficacy through wine-processing (Li and Wang, 2023). The Yaopin Huiyi further refined its meridian tropism, specifying its action on liver-gallbladder fire and associated disorders such as ocular pain and pediatric convulsions (Zhang, 2015).

Modern pharmacological studies validate its bioactive potential, demonstrating anti-inflammatory, analgesic, hepatoprotective, choleretic, antitumor, antioxidant, and digestive properties (Liu et al., 2024; Li et al., 2024; Zhang et al., 2023; Li, 2023; Wang et al., 2023). The 2020 Chinese Pharmacopoeia lists six gentian-containing formulas, including Longdan Xiegan Wan and Qingre Jiedu Koufuye, reflecting its clinical versatility. Clinically, it is widely employed in managing herpes zoster, hypertension, sudden deafness, and inflammatory conditions, with Longdan Xiegan Tang remaining a cornerstone therapy for damp-heat liver disorders. Globally, gentian is recognized as a bitter stomachic, underscoring its cross-cultural pharmacological relevance (Yang and Wang, 2005).

This integration of historical wisdom and contemporary science positions Gentianae Radix et Rhizoma as a multifaceted medicinal agent, bridging traditional applications with evidence-based therapeutic potential.

3.1 Anti-inflammatory and analgesic effects

As a pivotal herb in traditional heat-clearing and damp-drying therapies, Gentianae Radix et Rhizoma has garnered significant attention for its anti-inflammatory and analgesic properties. Modern studies reveal that these activities stem from multi-target and multi-pathway synergistic mechanisms, involving inflammation mediator regulation, signaling pathway modulation, and neurotransmitter adjustment, with demonstrated efficacy across diverse disease models.

3.1.1 Molecular mechanisms of anti-inflammatory action and disease intervention

The anti-inflammatory effects of Gentianae Radix et Rhizoma primarily target the NF-κB (Nuclear Factor κB) signaling axis. Experimental evidence confirms that its active component, gentiopicroside, inhibits IκB kinase β (IKKβ) phosphorylation, blocks NF-κB nuclear translocation, and subsequently downregulates key inflammatory mediators such as COX-2 (Cyclooxygenase-2) and TNF-α (Tumor Necrosis Factor-α). Gentiopicroside directly inhibits the phosphorylation of IKKβ, which prevents the degradation of IκB and subsequent nuclear translocation of the NF-κB p65 subunit. This blockade leads to the downregulation of key inflammatory mediators, including COX-2, TNF-α, and IL-6. Concurrently, gentiopicroside suppresses the activation of JNK and p38 within the MAPK pathway, further reducing the production of pro-inflammatory cytokines. In rheumatoid arthritis models, this mechanism significantly alleviates synovial inflammation and joint destruction. Concurrently, it suppresses JNK (c-Jun N-terminal Kinase)/p38 activation in the MAPK (Mitogen-Activated Protein Kinase) pathway, reducing macrophage secretion of IL-6 (Interleukin-6) and IL-1β (Interleukin-1β), thereby mitigating inflammatory infiltration in alcoholic liver injury. An in vivo study demonstrated that the ethyl acetate crude extract of Gentiana striata Maxim alleviated paw edema in a rat model of rheumatoid arthritis after 28 days of oral administration at doses of 100 and 200 mg/kg. This protective effect was associated with decreased levels of PGE_2_ and NO and was superior to that achieved with 100 mg/kg prednisone, a common anti-inflammatory drug (Cao et al., 2012). Notably, Gentianae Radix et Rhizomacomponents also remodel the inflammatory microenvironment via epigenetic regulation: in ulcerative colitis models, they promote macrophage polarization toward the M2 anti-inflammatory phenotype and inhibit histone deacetylase activity, enhancing chromatin accessibility of anti-inflammatory genes (Xie et al., 2021).

3.1.2 Multi-dimensional regulation of analgesic effects

The analgesic mechanisms of Gentianae Radix et Rhizoma extend beyond conventional anti-inflammatory frameworks, exerting analgesic effects through a central-peripheral synergistic network. Centrally, gentiopicroside downregulates NR2B (N-Methyl-D-aspartate receptor subunit 2B) subunit expression of NMDAR (N-Methyl-D-Aspartate Receptor) in the anterior cingulate cortex, inhibiting glutamatergic synaptic transmission and blocking pain sensitization (Chen et al., 2008). Peripherally, it reduces substance P release in the spinal dorsal horn and activates the μ-opioid receptor pathway to stimulate endogenous analgesic substances such as β-endorphin (Jia et al., 2012). In neuropathic pain models, this multi-target approach significantly alleviates mechanical allodynia and thermal hyperalgesia without inducing tolerance typically associated with traditional opioids (Xie et al., 2021). Particularly in chronic inflammatory pain, Gentianae Radix et Rhizoma synergistically enhance anti-inflammatory and analgesic outcomes by inhibiting PGE2 (Prostaglandin E2) synthesis and TRPV1 (Transient Receptor Potential Vanilloid 1) channel activation, offering novel strategies for managing inflammatory bowel disease. The specific compounds with anti-inflammatory and analgesic effects, as well as their mechanisms of action, are presented in Table 9.

3.2 Hepatoprotective and choleretic activities

Gentianae Radix et Rhizomaexerts hepatoprotective effects through a multidimensional “antioxidant-anti-inflammatory-metabolic modulation-anti-fibrotic” mechanism, while its choleretic activity is closely associated with bile acid transport regulation. Core constituents such as gentiopicroside and swertiamarin have emerged as pivotal lead compounds for liver disease drug development, particularly in alcohol-associated liver disease (ALD), metabolic dysfunction-associated steatotic liver disease, and hepatic fibrosis.

3.2.1 Hepatoprotective mechanisms

Crude Gentianae Radix et Rhizomaextracts and gentiopicroside significantly reduce ALT (Alanine Aminotransferase) and AST (Aspartate Aminotransferase) levels in acute liver injury models induced by CCl_4_ or D-galactosamine, while enhancing glutathione peroxidase and superoxide dismutase (SOD) activity, reducing malondialdehyde (MDA) accumulation, directly scavenging free radicals, and reinforcing hepatic antioxidant defenses (Kikuchi et al., 2005). Swertiamarin accelerates toxicant metabolism by activating cytochrome P450 family 3 subfamily A member 4 (CYP3A4) and cytochrome P450 family 2 subfamily E member 1 (CYP2E1) enzymes, thereby attenuating CCl_4_-induced hepatotoxicity. Oral swertiamarin (100–200 mg/kg, 8 weeks) alleviated CCl_4_-induced hepatotoxicity in rats by activating the Nrf2/HO-1 pathway, reducing oxidative stress and inflammation (Wu et al., 2017). Additionally, Gentianae Radix et Rhizomacomponents suppress NF-κB signaling, downregulating hepatic pro-inflammatory cytokines such as TNF-α and IL-6, thereby ameliorating lipopolysaccharide-and Bacillus Calmette-Guérin-induced liver injury. In ALD models, gentiopicroside targets the P2X purinoceptor 7 (P2X7) receptor/NOD-like receptor thermal protein domain-associated protein 3 (NLRP3) inflammasome axis, inhibiting inflammasome activation, reducing lipogenesis, and promoting lipid oxidation to alleviate alcoholic steatosis (Li X. et al., 2018). Swertiamarin exerts its hepatoprotective effects by activating the Nrf2 antioxidant pathway. Furthermore, gentiopicroside targets the P2X7 receptor, inhibiting NLRP3 inflammasome assembly and subsequent IL-1β maturation.

3.2.2 Anti-fibrotic interventions

Angiotensin system modulation: Swertiamarin inhibits AngII-AT1R signaling, blocking ERK (Extracellular Signal-Regulated Kinase)/c-Jun phosphorylation, thereby attenuating N-nitrosodimethylamine-induced hepatic stellate cell activation and fibrosis. The in vitro study using primary rat hepatic stellate cells showed that purified tetramethylpyrazine (5–20 μM, 12–24 h treatment) inhibited Ang II-induced activation, with DMSO as vehicle control and imatinib/rapamycin as positive controls (Zhang et al., 2014). This in vitro and in vivo study demonstrated that purified swertiamarin (Swe, 98% purity) at doses of 2.4–15 µM (in primary rat HSCs) and 15–20 mg/kg (in DMN-induced fibrotic rats) inhibited angiotensin II–induced activation and fibrosis, with losartan as a positive control and vehicle as negative control; treatment durations were 24 h (in vitro) and 2 weeks (in vivo), but no IC_50_/EC_50_ values were provided (Li et al., 2016). TGF-β1/Smad pathway regulation: G. rigescens suppresses TGF-β1/Smad2/3 signaling, downregulates connective tissue growth factor expression, reduces collagen deposition, and mitigates bleomycin-induced hepatic fibrosis (Li X. et al., 2018). Lipid metabolic balance: Gentiopicroside reduces triglyceride accumulation in ALD by modulating fatty acid synthase (FASN) and carnitine palmitoyltransferase 1 (CPT1) expression, restoring lipid oxidation-synthesis equilibrium. The study used acute and chronic alcoholic hepatosteatosis mouse models (40–80 mg/kg GPS) and ethanol-exposed HepG2 cells to show that purified genitopicroside (>99%) improved lipid metabolism via LKB1/AMPK activation and P2x7R–NLRP3 inflammasome inhibition. Metformin and A438079 served as positive controls, with treatments lasting 24 h (in vitro) to 10 days (in vivo); IC_50_/EC_50_ values were not provided (Lian et al., 2018).

3.2.3 Choleretic mechanisms

Swertiamarin enhances bile acid efflux by upregulating bile salt export pump (BSEP) and multidrug resistance-associated protein (MRP) expression, improving cholestasis. Crude Gentianae Radix et Rhizoma extracts increase hepatocyte membrane fluidity, enhance hepatic microcirculation, and alleviate biliary dysfunction in thioacetamide-induced models. In cecal ligation and puncture (CLP)-induced septic liver injury, gentiopicroside protects hepatocyte mitochondrial function by inhibiting inducible nitric oxide synthase activity and reducing excessive nitric oxide production (Zhang et al., 2022). The hepatoprotective and choleretic compounds in Gentianae Radix et Rhizoma, along with their bioactive components and mechanisms of action, are displayed in Table 10.

3.3 Antitumor activity

Gentianae Radix et Rhizomaexhibits broad-spectrum antitumor activity through multi-component interactions (e.g., gentiopicroside, polysaccharides, and Luteolin), targeting cell cycle regulation, apoptosis induction, autophagy modulation, and critical signaling pathway inhibition.

3.3.1 Inhibition of tumor cell proliferation and cell cycle arrest

Gentiopicroside activates the p38/MAPK signaling pathway, upregulates pro-apoptotic B-cell lymphoma-2-associated X protein (Bax), downregulates anti-apoptotic B-cell lymphoma-2 (Bcl-2), and suppresses proliferation in human ovarian cancer HO8910 cells. It induces S-phase and G2/M-phase arrest in hepatocellular carcinoma HepG2 cells while increasing the G0/G1-phase population, effectively inhibiting proliferation. This compound also significantly reduces viability in human liver cancer SMMC-7721 and lung cancer A549 cells. Gentianae Radix et Rhizoma polysaccharides enhance thymic and splenic indices in tumor-bearing mice post-chemotherapy, boosting immune responses. Additionally, compounds such as gentiakochianin and gentiacaulein induce apoptosis in glioma U251 cells by reducing mitochondrial membrane potential and promoting reactive oxygen species (ROS) generation. Luteolin inhibits non-small cell lung cancer (NSCLC) proliferation and induces autophagy via suppression of the PI3K/Akt/mTOR/p70S6K signaling axis. Furthermore, the study demonstrated through in vitro assays that certain triterpenoids isolated from Gentiana scabra exhibit potent inhibitory activity against human indoleamine 2,3-dioxygenase (IDO), with the most active compounds showing IC_50_ values below 10 μM (Li et al., 2015).

3.3.2 Multi-pathway antitumor effects

Crude Gentianae Radix et Rhizomaextracts inhibit proliferation in diverse cancer cell lines in vitro, including lung A549, colon HCT-116, prostate PC-3, and breast MCF-7 cells. In vivo, these extracts significantly suppress growth of mouse sarcoma S180 solid tumors, with medium- and high-dose groups showing tumor inhibition rates exceeding 30%. Specific compounds, such as chirat-16-en-3-one and chiratenol, demonstrate antiproliferative effects against cervical cancer HeLa cells. Globuloside A, cornusoside A, cornolactone A, 6,9-epi-8-O-acetylshanziside methyl ester, and polar extracts (petroleum ether, ethyl acetate) from Gentiana manshurica exhibit potent inhibition of HepG2 cell viability (Isakovic et al., 2008). The antitumor components in Gentianae Radix et Rhizoma, including their bioactive components and mechanisms of action, are presented in Table 11.

3.4 Regulation of gastrointestinal function

Gentiopicroside, a key bioactive component of G. scabra, improves gastrointestinal function through enhancing gastric motility, protecting gastric mucosa, and regulating gastrointestinal hormones.

3.4.1 Promotion of gastric motility

Gentiopicroside ameliorates stress-induced gastrointestinal dysmotility in rat models by upregulating motilin receptor expression and downregulating vasoactive intestinal peptide receptor 2 (VIPR2) levels, thereby enhancing gastric emptying and intestinal peristalsis (Ruan et al., 2015).

3.4.2 Gastric mucosal protection

In ethanol-induced gastric mucosal injury models, gentiopicroside upregulates heat shock protein-70 (HSP70), restores epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF) levels, and promotes mucosal repair (Yang et al., 2018). The gastrointestinal-regulating bioactive compounds in Gentianae Radix et Rhizoma and their mechanisms of action are presented in Table 12.

3.5 Regulation of the nervous system

The neuroregulatory properties of Gentianae Radix et Rhizomaare primarily mediated by its core constituent, gentiopicroside, which exerts neuroprotective, anti-neurodegenerative, and psychotherapeutic effects through multi-target synergy involving oxidative stress modulation, neurotransmitter regulation, and signaling pathway intervention.

3.5.1 Neuroprotective effects

Antioxidant Synergy and Cell Survival: Bellidifolin, gentisides A/B, amarogentin, and gentiopicroside enhance neuronal survival under oxidative stress (e.g., H_2_O_2_-induced PC12 cells) by activating insulin receptor downstream pathways, including PI3K/Akt and Ras/Raf/ERK. These compounds elevate superoxide dismutase (SOD, SOD2) activity, reduce ROS and MDA levels, and mitigate oxidative neuronal damage (Deng, 2015). Inokosterone further attenuates mitochondrial dysfunction-mediated apoptosis in oxidative stress models.

3.5.2 Cognitive enhancement

G. rigescens extracts enhance cognitive function in memory-impaired models by inhibiting acetylcholinesterase activity, thereby preserving acetylcholine levels, and by modulating the insulin-like growth factor 1 receptor and ERK signaling pathway (Ma, 2012).

3.5.3 Antidepressant and analgesic effects

Gentiopicroside alleviates pain-depression comorbidity in reserpine-induced models by downregulating glutamate NMDA receptor subunit 2B (GluN2B) subunit expression of NMDA receptors in the basolateral amygdala, reducing glutamatergic excitotoxicity. It also restores monoamine neurotransmitter balance (e.g., serotonin, dopamine), demonstrating antidepressant efficacy (Deng, 2015; Ma, 2012).

3.5.4 Anti-parkinsonian effects

In 6-hydroxydopamine-induced Parkinson’s disease models, gentiopicroside ameliorates motor deficits and tremors by inhibiting dopaminergic neuron degeneration in the nigrostriatal pathway, suppressing α-synuclein aggregation, and attenuating neuroinflammation (Yang, 2014).

3.5.5 Anti-addictive effects

Gentiopicroside reduces morphine-induced addictive behaviors by modulating opioid receptor signaling and dopamine reward pathways, reversing drug dependence-associated neuroplasticity (Ma, 2012).

3.5.6 Central nervous system stimulation

Early studies indicate that gentianine enhances central nervous system excitability in mice, potentially through γ-aminobutyric acid (GABA) ergic system modulation (Sun and Xia, 1984). The nervous system-regulating bioactive compounds in Gentianae Radix et Rhizoma and their mechanisms of action are presented in Table 13.

3.6 Antioxidant activity

Reports in the literature indicate that flavonoids and iridoids in Gentiana possess antioxidant activity. Li Peiyuan et al. (Li PY. et al., 2018) used the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical to measure the antioxidant capacity of Gentiana extracts and found that flavonoid compounds extracted with different solvents can effectively scavenge DPPH radicals, with antioxidant activity being directly proportional to the total flavonoid content. Additionally, GSP-IIb, GSP-IIa and iridoid compounds isolated from the rhizomes of Gentiana can scavenge DPPH radicals, exhibiting stable antioxidant activity (Suyama et al., 2013). Gentirigeoside B exerts antioxidant effects by inhibiting the mTOR/Sch9/Rim15/Msn signaling pathway and enhancing autophagy (Xiang et al., 2022). Furthermore, in vitro assays of 60% methanol extracts from six Caucasian Gentiana species (herbs and roots) demonstrated antioxidant (DPPH, superoxide scavenging, lipid peroxidation inhibition) and digestive enzyme inhibitory (α-amylase/α-glucosidase) activities, with positive controls including trolox, quercetin, caffeic acid, and acarbose; activity strongly correlated with phenolic content, though no specific IC_50_ values or dose ranges for crude extracts were provided (Olennikov et al., 2019). The antioxidant bioactive compounds in Gentianae Radix et Rhizoma and their mechanisms of action are presented in Table 14.

3.7 Other effects

In vivo studies in normal, glucose-hyperglycemic, and streptozotocin-induced diabetic rats demonstrated that the ethyl acetate fraction of a methanol extract of Gentiana olivieri aerial parts, and its isolated active constituent isoorientin (doses: 7.5–30 mg/kg), significantly reduced blood glucose levels, with a minimal effective dose of 15 mg/kg; positive controls included tolbutamide, negative controls received vehicle, and treatment durations ranged from acute (four to six h) to subacute (15 days) administration (Sezik et al., 2005). Gentianae Radix et Rhizoma extracts and have demonstrated the ability to reduce the activity of hepatic enzymes such as alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase, as well as modulate the bile acid receptor G protein-coupled bile acid receptor 1 (TGR5)/β-arrestin2/NF-κB signaling pathway, thereby delaying the progression of diabetic nephropathy in mice fed a high-fat diet (Ghazanfar et al., 2017; Xi et al., 2020). Gentiopicroside can be utilized to improve skin conditions with impaired epidermal barriers (Wölfle et al., 2017); it also inhibits adipogenesis by modulating the 3T3-L1 pathway (Choi et al., 2019). Gentianae Radix et RhizomaBunge. Exhibits significant activity against adenovirus type 5 (C type), human rhinovirus type B (subtype 14), and respiratory syncytial virus; the underground parts of Gentianae Radix et Rhizoma possess diuretic effects (You, 2017). The other bioactivities of Gentianae Radix et Rhizoma are presented in Table 15.

Notwithstanding its wide spectrum of pharmacological activities, it is crucial to consider its safety profile; traditional wisdom cautions against its use in cases of spleen-stomach deficiency with cold symptoms due to its potent bitter and cold nature (Zhu et al., 2021), while modern toxicological assessments indicate a relatively low acute toxicity (LD_50_ > 5 g/kg in mice) and an absence of genotoxic concern as per OECD guidelines.

4 Clinical applications

As a classic herb in traditional Chinese medicine (TCM) for clearing heat, drying dampness, and purging liver-gallbladder fire, Gentianae Radix et Rhizoma has demonstrated enduring clinical value through centuries of practice. Modern research on its compound formulations and bioactive constituents has expanded its applications beyond traditional liver-gallbladder damp-heat syndromes to dermatological, cardiovascular, gynecological, otolaryngological, and systemic disorders, establishing a modern therapeutic framework integrating “disease-pattern differentiation, formula compatibility, and mechanistic clarity”.

4.1 Dermatological disorders: herpes zoster and postherpetic neuralgia

Herpes zoster, caused by reactivation of varicella-zoster virus (VZV), is attributed to liver fire hyperactivity and damp-heat toxin accumulation in TCM. G. scabra-based formulas exert antiviral, immunomodulatory, and analgesic effects (Sun and Sun, 2007; Liu et al., 2021).

4.1.1 Acute phase treatment

Longdan Xiegan Tang (Gentian Liver-Draining Decoction) (Cao, 2022; Wu and Chen, 2022; Zhang and Zhang, 2018): Combining Gentianae Radix et Rhizoma (as the sovereign herb) with Scutellaria and Gardenia, this formula alleviates herpetic pain and accelerates crust formation.

4.1.2 Inhibition of VZV replication and viral load reduction

Downregulation of serum TNF-α and IL-6, upregulation of IL-12 and CD3+/CD4+ T cells to enhance Th1 immune responses. Modulation of neuropeptides (e.g., substance P, β-endorphin) to reduce neurogenic inflammation.Longdan Jiedu Tang (Gentian Toxin-Resolving Decoction) (Sun and Sun, 2007): Enhanced with Isatis root and Clerodendrum, this formula shows superior efficacy in bacterial co-infections by reducing IgE levels, suppressing mast cell degranulation, and inhibiting histamine release to alleviate pruritus.

4.1.3 Postherpetic neuralgia management

Longdan Shenmai Zhijing Tang (Gentian-Ginseng Spasm-Relieving Decoction) (Shao et al., 2022): Targets residual damp-heat and qi-yin deficiency by inhibiting spinal dorsal horn glial cell activation, reducing IL-1β/TNF-α-mediated neuro-sensitization, and upregulating neurotrophic factors for nerve repair. Bloodletting Acupuncture Combined Therapy: Adjunctive use with modified Longdan Xiegan Tang enhances CD8^+^ T cell activity and cytotoxic T lymphocyte responses to eliminate pathogens and restore microcirculation.

4.1.4 Special localizations

Ramsay Hunt Syndrome: Longdan Dai Xie Xiao Zhen Tang (Gentian-Indigo-Scorpion Rash-Resolving Decoction) achieves an 89.3% efficacy rate by suppressing VZV reactivation in trigeminal ganglia and reducing vestibular nerve edema, improving otalgia and facial paralysis (Zhang, 2009).

4.2 Cardiovascular disorders: Hypertension and complications

Longdan Xiegan Tang exemplifies integrated TCM-Western therapy for liver fire-induced hypertension, targeting mechanisms such as: Blood Pressure Regulation: Suppression of angiotensin II/AT1 receptor signaling to counteract vasoconstriction and myocardial fibrosis. Activation of eNOS/NO pathway and inhibition of endothelin-1 to restore endothelial function. Metabolic Syndrome Management: Reduces total cholesterol, low-density lipoprotein, and blood pressure variability through HMG-CoA reductase inhibition, bile acid excretion, and modulation of the autonomic nervous system, particularly by enhancing vagal tone (Li, 2023; Li, 2014; Li, 1998; Yang et al., 2022; Zheng and RUAN, 2018; Zuo et al., 2020).

4.3 Hepatobiliary disorders: chronic hepatitis B and fatty liver

4.3.1 Chronic hepatitis B

Fufang Xiongdan Yigan Jiaonang (Compound Bear Bile Hepatitis Capsule) (Hu and Li, 2002): Inhibits Hepatitis B virus DNA replication and promotes HBeAg seroconversion by blocking viral transcription and enhancing interferon-γ responses. Modified Longdan Xiegan Tang: Reduces liver stiffness and fibrosis via TGF-β1/Smad3 pathway inhibition and matrix metalloproteinase activation (Liu et al., 2017; Lyu and Lin, 2018; Wang et al., 2017).

4.3.2 Non-alcoholic fatty liver disease

Gentiopicroside activates PPARα/CPT1 to enhance fatty acid β-oxidation and suppresses SREBP-1c-mediated lipogenesis. Combined with lifestyle intervention, Longdan Xiegan Tang reduces hepatic steatosis and serum free fatty acids (Ge et al., 2022).

4.4 Gynecological inflammation: Cervicitis, vaginitis, and HPV infection

Cervicitis with HPV: Longdan Xiegan Tang downregulates cervical IL-8, TNF-α, and HPV E6/E7 oncoprotein expression while enhancing secretory IgA and dendritic cell antigen presentation (Dai et al., 2023; Zhou, 2012; Zhou et al., 2013a; Zhou et al., 2013b; Jiang, 2018). Bacterial Vaginosis: Modified formulations disrupt biofilms, inhibit bacterial adhesins, and restore vaginal microbiota (lactobacilli increased by three to four log units; pH < 4.5) (Liu et al., 2017; Lyu and Lin, 2018; Wang et al., 2017).

4.5 Otolaryngological and ophthalmic disorders

Otitis Media: Longdan Xiegan Capsules with tympanocentesis reduce middle ear effusion and TGF-β1/β2 levels via TLR4/MyD88/NF-κB pathway inhibition (Su and Mou, 2022). Chronic Rhinosinusitis: Corrects Th17/Treg imbalance by suppressing IL-17A/IL-22 and improving Lund-Kennedy endoscopic scores (Li, 2020). Herpetic Keratitis: Longdan Mingmu Tang (Gentian Vision-Clearing Decoction) with ganciclovir inhibits HSV UL54 gene expression and enhances corneal repair (Huo and Guo, 2000; Qu, 2022). Acupuncture adjunct therapy modulates trigeminal ganglion microRNAs (miR-155, miR-146a) to reduce recurrence (Lu and Su, 2018).

4.6 Emerging applications

Diabetic Nephropathy: Gentiana extracts attenuate renal fibrosis via TGR5 receptor activation, inhibiting tubular epithelial-mesenchymal transition (EMT) and NF-κB-driven inflammation (Jiang et al., 2019). Chronic Kidney Disease: Diuretic effects of Gentiana roots match furosemide in sodium excretion but with reduced potassium loss, offering safer edema management (Huang, 2020).

The clinical applications and mechanisms of Gentianae Radix et Rhizoma and its compound formulations are illustrated in Figure 9.

Clinical applications and Mechanisms of Gentianae Radix et Rhizoma and Its compound formulations.

5 Discussion and prospects

Gentianae Radix et Rhizoma, as a cornerstone of traditional and modern medicine, exhibits multifaceted therapeutic potential owing to its diverse chemical constituents and broad pharmacological activities. Despite significant advancements in identifying over 170 compounds, including terpenoids, flavonoids, and alkaloids, gaps remain in fully elucidating its chemical diversity. However, there is significant variation in efficacy between different species of Gentiana, such as G. scabra and G. rigescens. These species differ in their chemical profiles, which may affect their pharmacological actions. For instance, G. scabra is known for higher concentrations of certain iridoids like gentiopicroside, which contributes to its prominent anti-inflammatory and hepatoprotective properties. On the other hand, G. rigescens contains higher levels of specific triterpenoids, which may play a more substantial role in its antitumor and neuroprotective effects. These variations in chemical composition highlight the importance of considering species-specific differences when evaluating the therapeutic potential of Gentiana-based formulations. Advanced techniques such as metabolomics and AI-driven structural prediction could further uncover novel bioactive molecules, particularly minor or unstable constituents overlooked in conventional studies.

While the anti-inflammatory, hepatoprotective, and antitumor effects of key components like gentiopicroside and swertiamarin are well-documented, their molecular mechanisms—especially in modulating signaling pathways (e.g., TLR4/NF-κB, PI3K/Akt)—require deeper exploration. For instance, the interplay between gut microbiota and gentiopicroside’s neuroprotective effects or the epigenetic regulation of triterpenoids in fibrosis warrants systematic investigation.

Clinically, expanding applications beyond liver-gallbladder disorders to metabolic syndromes (e.g., diabetes, obesity) and neurodegenerative diseases (e.g., Parkinson’s, Alzheimer’s) represents a promising frontier. However, this necessitates rigorous clinical trials to validate efficacy and safety. Quality control remains a challenge; standardized protocols for active compound quantification, coupled with genomic and metabolomic fingerprinting, are critical to ensure batch consistency and minimize toxicity risks.

Furthermore, synergistic or antagonistic interactions between Gentiana extracts and conventional drugs (e.g., chemotherapeutics, antihypertensives) must be evaluated to optimize integrated therapies. Long-term toxicity studies and eco-friendly extraction methods should also be prioritized to align with sustainable pharmaceutical practices.

In summary, interdisciplinary collaboration—bridging phytochemistry, pharmacology, and clinical research—will unlock the full potential of Gentianae Radix et Rhizoma, transforming traditional wisdom into evidence-based solutions for global healthcare challenges.